“Effect of Subcutaneous Spesolimab on the Prevention of Generalized Pustular Psoriasis Flares Over 48 weeks: Subgroup Analyses from the Effisayil 2 Trial ”, J of Skin, vol. 7, no. 6, p. s245, Nov. 2023, doi: 10.25251/skin.7.supp.245.